| 1. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| 2. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
|
| 3. |
Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975-2016, updated December 11, 2019, posted at https://seer.cancer.gov/statistics/reports.html.
|
| 4. |
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
|
| 5. |
Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med, 2013, 369(10): 920-931.
|
| 6. |
National Lung Screening Trial Research Team, Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med, 2013, 368(21): 1980-1991.
|
| 7. |
Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisci-plinary Classification of Lung Adenocarcinoma. J Thorac Oncol, 2011, 6(2): 244-285.
|
| 8. |
Loomis D, Guha N, Hall AL, et al. Identifying occupational carcinogens: an update from the IARC Monographs. Occup Environ Med, 2018, 75(8): 593-603.
|
| 9. |
Delva F, Margery J, Laurent F, et al. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. BMC Public Health, 2017, 17(1): 191.
|
| 10. |
Wu GX, Nelson RA, Kim JY, et al. Non-small cell lung cancer as a second primary among patients with previous malignancy: Who is at risk? Clin Lung Cancer, 2017, 18(5): 543-550.
|
| 11. |
Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA, 2004, 292(24): 2977-2983.
|
| 12. |
Li X, Hemminki K. Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer, 2005, 47(3): 301-307.
|
| 13. |
Marshall HM, Bowman RV, Yang IA, et al. Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis, 2013, 5(Suppl 5): S524-S539.
|
| 14. |
Yip R, Henschke CI, Xu DM, et al. Lung cancers manifesting as part-solid nodules in the National Lung Screening Trial. AJR Am J Roentgenol, 2017, 208(5): 1011-1021.
|
| 15. |
Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology, 2013, 266(1): 304-317.
|
| 16. |
Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5 Suppl): e93S-e120S.
|
| 17. |
Mazzone PJ, Silvestri GA, Patel S, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest, 2018, 153(4): 954-985.
|
| 18. |
Detterbeck FC. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue? Thorax, 2014, 69(5): 407-408.
|
